Join Cambia Grove for The Payer Perspective with Nic Anderson, Managing Partner at LDD Partners, and Jeremy Porter, Operating Partner at Waveny Ventures, to discuss incorporating health economics and a market access strategy into your business plan to appeal to payer systems. This Lunch & Learn will be taking place virtually. *everyone that RSVPs will receive a […]
Corona or COVID-19 has done that which humans could never have… work from home, audit remotely, troubleshoot remotely, and the list can go on. If this change is here to stay we will need to adjust and find ways to march forward. While certain things change, some remain pretty much the same; among those is […]
Due to the supply chain disruptions in Asia caused by the Covid-19 pandemic, it is important to identify alternatives. Join World Trade Center Utah, Dezan Shira & Associates’ Dustin Daugherty and Harris Bricken’s Jonathan Bench for a webinar comparing markets in Southeast Asia as you search for new sourcing and direct investment opportunities. […]
HB Group is a local firm that has been successfully importing Personal Protective Equipment for use by Utah businesses. They have supplied significant amounts of the product to the states of Utah and New York and are now making their services available to local businesses. HB Group can also supply CE Certs, additional specifications and testing […]
Corona or COVID-19 has done that which humans could never have… work from home, audit remotely, troubleshoot remotely, and the list can go on. If this change is here to stay we will need to adjust and find ways to march forward differently. While certain things change, some remain pretty much the same; among those […]
How can we advance the utilization of innovations in healthcare? By lending them extra visibility to key stakeholders! Join the Impactful Innovation Exchange, a free comprehensive platform that will showcase solutions from various organizations, created by Cambia Grove, with supporting organizations including BioUtah. Learn more and submit yours for FREE today: https://bit.ly/CGInnovationSubmission […]
Marcy l’Étoile, France – March 24, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that its subsidiary, BioFire Defense, has received Emergency Use Authorization by the U.S. Food and Drug Administration of its BIOFIRE® COVID-19 test for use in CLIA moderate and high complexity clinical laboratories to detect SARS-CoV-2. The BIOFIRE® COVID-19 test detects […]
The Advanced Medical Technology Association (AdvaMed) has consistently indicated that the United States should not be imposing tariffs on medical technology. USTR’s moves in that direction are welcome. We are grateful to USTR for its recent decision to grant exclusions for a range of personal protective equipment (PPE) imports from China. This action could help […]
PhotoPharmics, a pioneer in specialized phototherapy, announced on April 29, that it has received FDA Breakthrough device designation for the company’s non-invasive Specialized Phototherapy Device. “Hats off to Utah’s PhotoPharmics,” said Kelvyn Cullimore, president and CEO of BioUtah. “Earning this Breakthrough designation is a significant value driver for a privately-owned device company.” “Our device is […]
Summary: This procedure was performed to evaluate the particle penetration and air flow resistance properties of filtration materials. A neutralized, poly-dispersed aerosol of sodium chloride(NaCI) was generated and passed through the test article. The performance of the test article was assessed by measuring the concentration of salt particles penetrating the test article compared to the […]
Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces that the KidneyIntelX™ platform will be used by investigators from the Icahn School of Medicine at Mount Sinai to assess the risk of adverse kidney events in patients diagnosed with COVID-19. Acute and chronic kidney disease is strongly associated with severity […]
PhotoPharmics achieves priority designation for innovative PD therapy April 29, 2020, Salt Lake City, UT— PhotoPharmics, a pioneer in specialized phototherapy, today announced that it has received FDA Breakthrough device designation for the company’s non-invasive Specialized Phototherapy Device. This prescription device is intended as an adjunct therapy for the treatment of Parkinson’s disease. It is […]